Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jennifer Elizabeth Murphy
Observed names:
Jennifer E Murphy,
Jennifer E. Murphy
Institutions:
University Hospitals of Cleveland,
University Hospitals Cleveland Medical Center
Observed institutions:
University Hospitals of Cleveland,
University Hospitals Cleveland Medical Center
OpenAlex ID:
A5111219360
GLP-1 receptor agonist use and pancreatic cancer risk in patients with chronic pancreatitis.
2026
·
Sarina Ailawadi
, Jennifer Elizabeth Murphy
, et al.
·
Journal of Clinical Oncology
·
1
PDF
GLP-1 receptor agonist use and colorectal cancer risk in patients with inflammatory bowel disease.
2026
·
Sarina Ailawadi
, Jennifer Elizabeth Murphy
, et al.
·
Journal of Clinical Oncology
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) versus statins and the risk of hepatocellular carcinoma (HCC) and hepatic decompensation in patients with type 2 diabetes mellitus (T2DM).
2026
·
Sarina Ailawadi
, Jennifer Elizabeth Murphy
, et al.
·
Journal of Clinical Oncology
Comparative clinical outcomes with lenvatinib versus cabozantinib post-progression on first-line immunotherapy in patients with advanced hepatocellular carcinoma.
2026
·
Sarina Ailawadi
, Jennifer Elizabeth Murphy
, et al.
·
Journal of Clinical Oncology
Survival and functional outcomes in octogenarians with lung cancer.
2026
·
Mackenzie Deighen
, Zhiting Tang
, et al.
·
Journal of Clinical Oncology
Comparative outcomes of first-line atezolizumab plus bevacizumab (A+B) and durvalumab plus tremelimumab (D+T) in hepatocellular carcinoma (HCC).
2026
·
Sarina Ailawadi
, Jennifer Elizabeth Murphy
, et al.
·
Journal of Clinical Oncology
Skin and soft tissue infections in pediatric patients with inflammatory bowel disease treated with tumor necrosis factor-α inhibitors
2026
·
Jordan Kahle
, Hailey Seibert
, et al.
·
Journal of the American Academy of Dermatology
Mo1894: NO INCREASED RISK OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROPENSITY MATCHED MULTINETWORK STUDY
2025
·
Abdullah Mahmood
, Shaina Ailawadi
, et al.
·
Gastroenterology
S366 Pembrolizumab Predominantly Causes Microscopic Colitis That Responds to Oral Budesonide in Patients Who Develop Immune Checkpoint Inhibitor Colitis: A Retrospective Single Site Observational Study
2024
·
Pearl Aggarwal
, Jaime A. Perez
, et al.
·
The American Journal of Gastroenterology
A single institution review of immunotherapy use, adverse events, and outcomes in early-onset cancer.
2024
·
Michael Daunov
, Chaim Domb
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
